Skip to content

Isokinetic Exercises in Patients With Multiple Sclerosis

The Effects of Isokinetic Exercises on Muscle Strength, Joint Position Sense, and Kinesiophobia in Patients With Multiple Sclerosis: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03779724
Enrollment
50
Registered
2018-12-19
Start date
2015-07-29
Completion date
2016-07-29
Last updated
2019-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

multiple sclerosis, isokinetic, exercises, joint position sense, kinesiophobia

Brief summary

The investigators evaluated the effects of isokinetic muscle strengthening exercises of the quadriceps and hamstring on muscle strength, joint position sense, pain, kinesiophobia and quality of life in patients with multiple sclerosis.

Detailed description

Objective: To evaluate the effects of isokinetic exercises on muscle strength, knee joint position sense, pain, kinesiophobia, and quality of life in patients with multiple sclerosis. Design: Randomized controlled trial. Setting: Outpatient clinic. Participants: Fifty patients with multiple sclerosis. Interventions: Fifty patients who met the inclusion criteria were randomized to an isokinetic exercise (n:25) or home exercise programme (n:25). Sequentially numbered opaque envelopes were used for randomization. Outcome measures: The outcome measures were the peak torque/body mass index of quadriceps and hamstring muscles at 60°/s and 180°/s velocities, the hamstring/quadriceps ratios at the same velocities, absolute angular errors of the 15°, 45°, and 60° and the mean absolute angular error of joint position sense of the less and more affected knees, and the scores of Multiple Sclerosis Quality of Life-54, Visual Analogue Scale, and Tampa Scale of Kinesiophobia.

Interventions

OTHERexercises

Sponsors

Aksaray University Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This prospective randomized controlled trial aimed to recruit 50 patients with MS from the physical medicine and rehabilitation clinic of Ankara Training and Research Hospital, Health Sciences University, Ankara, Turkey. Fifty patients who met the inclusion criteria were enrolled in the study. Fifty patients were randomized to two groups: isokinetic exercise (Group 1) (n=25) and home exercise (Group 2) (n=25). Randomization was completed using sequentially numbered, opaque envelopes by the investigator. All patients gave informed consent before the assessment. The outcome measures were assessed initially and at eighth week after the treatment. Group 1 performed isokinetic concentric quadriceps and hamstring strengthening exercises under supervision and Group 2 performed lower extremity muscle strengthening and balance exercises at home.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* definite relapsing remitting MS and secondary progressive MS diagnosis * mild and moderate MS determined by Kurtzke Expanded Disability Status Scale (EDSS) scores below 6.5 * a disease duration of more than one year.

Exclusion criteria

* having an acute exacerbation within the last three months * intravenous pulse steroid therapy in the last four weeks * grade 3-4 spasticity according to the Modified Ashworth Scale * severe vision impairment * severe fatigue and depression * past knee surgery * other neurologic diseases * systemic diseases * pregnancy * having received an exercise program within the last four weeks.

Design outcomes

Primary

MeasureTime frameDescription
Isokinetic Muscle Strength Test of the More and Less Affected KneesAt baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatmentThe peak torque/body mass index of the quadriceps and hamstring muscles at 60°/s and 180°/s velocities were measured by an isokinetic dynamometer (Biodex Multijoint Pro 3) in Newton/meter. A definite muscle strength value has not been defined. Literally, healthy controls and patients are compared. Higher scores indicate better muscle strength.
Joint Position Sense of the More and Less Affected KneesAt baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatmentAbsolute angular errors of the 15°, 45°, and 60° and the mean absolute angular error of the more and less affected knees were measured by an isokinetic dynamometer (Biodex Multijoint Pro 3) with active-active angular reproduction method. Estimating the target angel procedure was repeated at 45°, 15°, and 60° and for both the more and less affected legs. After the joint position sense testing, three angles estimated by the patients were averaged, and the angular error was calculated for each target angle. Absolute angular error was calculated by averaging the angular errors, regardless of the numbers being negative or positive. The absolute angular error values of the three target angles were averaged to obtain the mean absolute angular errors. A definite angular error value has not been defined. Literally, healthy controls and patients are compared. Higher scores indicate worser joint position sense.
Tampa Scale of KinesiophobiaAt baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatmentKinesiophobia which is described as fear of movement and physical activity was evaluated using the Tampa Scale of Kinesiophobia, which is a 17-item self-report survey. The range of scores are from 17 to 68 where the higher scores indicate an increasing degree of kinesiophobia. If the total score was above 37 points, the patient was considered to have a high level of kinesiophobia.
Multiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreAt baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatmentThis is a multidimensional health-related quality of life measure that combines both generic and multiple sclerosis-specific symptoms in a single instrument. The 54 items are divided into 12 multi-item and 2 single-item scales.Health distress, overall quality of life, emotional well-being, role limitations-emotional and cognitive funtion items' final scores averaged and mental composite score was calculated. Physical function, health perceptions, energy/fatigue, role limitations-physical, pain, sexual function, social function, health distress items' final scores were averaged and physical composite score was obtained.Total score was obtained by averaging the mental and physical composite scores.Final scores can be between 0-100 points for total, mental, physical and pain scores. Higher values indicate better quality of life for total, physical and mental scores and worser pain levels for pain score.
Visual Analog ScaleAt baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatmentPain intensity was evaluated with the Visual Analog Scale. Using a ruler, a 10 cm line was drawn which provided a range of scores from 0-100. Than the patients marked the point that showed their pain intensity on this line. A higher score in Visual Analog Scale indicates greater pain intensity.

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

This prospective randomized controlled trial aimed to recruit 50 patients with multiple sclerosis from the physical medicine and rehabilitation clinic of Ankara Training and Research Hospital, Health Sciences University, Ankara, Turkey.

Participants by arm

ArmCount
Isokinetic Exercise
The isokinetic dynamometer (Biodex Multijoint Pro 3) was used for isokinetic exercises. The isokinetic exercise program was implemented over eight weeks, twice a week on non-consecutive days under the supervision of a doctor. The number of repetitions undertaken by the patients over the program were as follows: first week 5 at 60°/s and 10 at 180°/s, second week 10 at 60°/s and 15 at 180°/s, third week 15 at 60°/s and 20 at 180°/s, fourth week 20 at 60°/s and 30 at 180°/s, and in the last four weeks 20 at 60°/s and 40 at 180°/s angular velocities. Each block of 10 repetitions were performed as a set. exercises
19
Home Exercise
The patients undertook lower extremity strengthening and balance exercises three times a week for eight weeks without supervision. They started with three repetitions, which was gradually increased to 10-15. The patients were called two times a week to inquire about exercise continuity and encouraged to undertake the recommended exercises. exercises
21
Total40

Baseline characteristics

CharacteristicHome ExerciseTotalIsokinetic Exercise
Age, Continuous39.95 years
STANDARD_DEVIATION 12.25
39.60 years
STANDARD_DEVIATION 10.63
39.21 years
STANDARD_DEVIATION 8.81
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Turkey
21 Participants40 Participants19 Participants
Sex: Female, Male
Female
14 Participants27 Participants13 Participants
Sex: Female, Male
Male
7 Participants13 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Isokinetic Muscle Strength Test of the More and Less Affected Knees

The peak torque/body mass index of the quadriceps and hamstring muscles at 60°/s and 180°/s velocities were measured by an isokinetic dynamometer (Biodex Multijoint Pro 3) in Newton/meter. A definite muscle strength value has not been defined. Literally, healthy controls and patients are compared. Higher scores indicate better muscle strength.

Time frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment

ArmMeasureGroupValue (MEAN)Dispersion
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(more affected knee)82.46 Newton/meterStandard Deviation 43.96
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(less affected knee)59.87 Newton/meterStandard Deviation 24.51
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring/Quadriceps(more affected knee)0.92 Newton/meterStandard Deviation 0.58
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring/Quadriceps(more affected knee)0.77 Newton/meterStandard Deviation 0.27
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(more affected knee)42.25 Newton/meterStandard Deviation 25.19
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(less affected knee)46.74 Newton/meterStandard Deviation 17.76
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s hamstring/quadriceps(less affected knee)0.63 Newton/meterStandard Deviation 0.14
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(less affected knee)69.25 Newton/meterStandard Deviation 24.28
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(more affected knee)58.87 Newton/meterStandard Deviation 33.6
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s hamstring/quadriceps (less affected knee)0.80 Newton/meterStandard Deviation 0.19
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(less affected knee)110.48 Newton/meterStandard Deviation 37.2
Isokinetic Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(more affected knee)52.42 Newton/meterStandard Deviation 25.08
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(less affected knee)85.87 Newton/meterStandard Deviation 21
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(more affected knee)118.50 Newton/meterStandard Deviation 45.52
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(less affected knee)141.05 Newton/meterStandard Deviation 31.59
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring/Quadriceps(more affected knee)0.65 Newton/meterStandard Deviation 0.12
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(more affected knee)77.70 Newton/meterStandard Deviation 29.27
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s hamstring/quadriceps(less affected knee)0.61 Newton/meterStandard Deviation 0.12
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(more affected knee)51.38 Newton/meterStandard Deviation 23.24
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(less affected knee)82.87 Newton/meterStandard Deviation 23.11
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring/Quadriceps(more affected knee)0.66 Newton/meterStandard Deviation 0.19
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(less affected knee)56.85 Newton/meterStandard Deviation 19.74
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(more affected knee)73.62 Newton/meterStandard Deviation 23.53
Isokinetic Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s hamstring/quadriceps (less affected knee)0.69 Newton/meterStandard Deviation 0.19
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring/Quadriceps(more affected knee)0.94 Newton/meterStandard Deviation 0.58
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(less affected knee)123.02 Newton/meterStandard Deviation 53.8
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(less affected knee)72.85 Newton/meterStandard Deviation 29.02
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s hamstring/quadriceps(less affected knee)0.61 Newton/meterStandard Deviation 0.14
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(less affected knee)71.06 Newton/meterStandard Deviation 32.01
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(less affected knee)53.73 Newton/meterStandard Deviation 22.55
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s hamstring/quadriceps (less affected knee)0.76 Newton/meterStandard Deviation 0.22
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(more affected knee)100.16 Newton/meterStandard Deviation 47.85
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(more affected knee)67.00 Newton/meterStandard Deviation 30.87
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring/Quadriceps(more affected knee)0.71 Newton/meterStandard Deviation 0.22
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(more affected knee)57.18 Newton/meterStandard Deviation 30.59
Home Exercise BaselineIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(more affected knee)46.19 Newton/meterStandard Deviation 22.2
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring/Quadriceps(more affected knee)0.71 Newton/meterStandard Deviation 0.22
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s hamstring/quadriceps (less affected knee)0.74 Newton/meterStandard Deviation 0.18
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(less affected knee)56.76 Newton/meterStandard Deviation 21.21
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(less affected knee)127.83 Newton/meterStandard Deviation 54.35
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(more affected knee)62.03 Newton/meterStandard Deviation 29.38
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Quadriceps PT/BMI(less affected knee)76.54 Newton/meterStandard Deviation 28.73
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s hamstring/quadriceps(less affected knee)0.62 Newton/meterStandard Deviation 0.12
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring/Quadriceps(more affected knee)0.85 Newton/meterStandard Deviation 0.48
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees180°/s Hamstring PT/BMI(more affected knee)48.08 Newton/meterStandard Deviation 23.38
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(more affected knee)72.80 Newton/meterStandard Deviation 31.55
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Quadriceps PT/BMI(more affected knee)108.06 Newton/meterStandard Deviation 48.83
Home Exercise After TreatmentIsokinetic Muscle Strength Test of the More and Less Affected Knees60°/s Hamstring PT/BMI(less affected knee)78.40 Newton/meterStandard Deviation 31.21
Primary

Joint Position Sense of the More and Less Affected Knees

Absolute angular errors of the 15°, 45°, and 60° and the mean absolute angular error of the more and less affected knees were measured by an isokinetic dynamometer (Biodex Multijoint Pro 3) with active-active angular reproduction method. Estimating the target angel procedure was repeated at 45°, 15°, and 60° and for both the more and less affected legs. After the joint position sense testing, three angles estimated by the patients were averaged, and the angular error was calculated for each target angle. Absolute angular error was calculated by averaging the angular errors, regardless of the numbers being negative or positive. The absolute angular error values of the three target angles were averaged to obtain the mean absolute angular errors. A definite angular error value has not been defined. Literally, healthy controls and patients are compared. Higher scores indicate worser joint position sense.

Time frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment

ArmMeasureGroupValue (MEAN)Dispersion
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of less affected knee5.56 degreeStandard Deviation 2.78
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of lmore affected knee4.94 degreeStandard Deviation 3.06
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Knees15° joint position sense of less affected knee6.26 degreeStandard Deviation 4.7
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Knees15° joint position sense of more affected knee4.61 degreeStandard Deviation 3.79
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Knees45° joint position sense of less affected knee6.41 degreeStandard Deviation 3.61
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Knees45° joint position sense of more affected knee4.73 degreeStandard Deviation 3.81
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Knees60° joint position sense of less affected knee3.40 degreeStandard Deviation 3.08
Isokinetic Exercise BaselineJoint Position Sense of the More and Less Affected Knees60° joint position sense of more affected knee6.02 degreeStandard Deviation 4.99
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees45° joint position sense of more affected knee4.21 degreeStandard Deviation 2.95
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees45° joint position sense of less affected knee5.86 degreeStandard Deviation 3.95
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of lmore affected knee4.38 degreeStandard Deviation 1.94
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees60° joint position sense of more affected knee4.17 degreeStandard Deviation 2.52
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees60° joint position sense of less affected knee3.39 degreeStandard Deviation 3
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees15° joint position sense of more affected knee0.74 degreeStandard Deviation 4.04
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees15° joint position sense of less affected knee3.87 degreeStandard Deviation 4.28
Isokinetic Exercise After TreatmentJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of less affected knee4.39 degreeStandard Deviation 2.32
Home Exercise BaselineJoint Position Sense of the More and Less Affected Knees60° joint position sense of less affected knee4.55 degreeStandard Deviation 4.78
Home Exercise BaselineJoint Position Sense of the More and Less Affected Knees15° joint position sense of less affected knee5.93 degreeStandard Deviation 5.26
Home Exercise BaselineJoint Position Sense of the More and Less Affected Knees15° joint position sense of more affected knee4.96 degreeStandard Deviation 4.05
Home Exercise BaselineJoint Position Sense of the More and Less Affected Knees45° joint position sense of less affected knee6.23 degreeStandard Deviation 4.36
Home Exercise BaselineJoint Position Sense of the More and Less Affected Knees45° joint position sense of more affected knee5.80 degreeStandard Deviation 5
Home Exercise BaselineJoint Position Sense of the More and Less Affected Knees60° joint position sense of more affected knee4.18 degreeStandard Deviation 6.67
Home Exercise BaselineJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of less affected knee5.70 degreeStandard Deviation 3.19
Home Exercise BaselineJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of lmore affected knee5.76 degreeStandard Deviation 5.35
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees15° joint position sense of less affected knee5.32 degreeStandard Deviation 4.07
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees15° joint position sense of more affected knee5.27 degreeStandard Deviation 3.82
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of lmore affected knee4.99 degreeStandard Deviation 3.59
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Kneesmean absolute angular error of less affected knee5.03 degreeStandard Deviation 2.65
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees45° joint position sense of less affected knee4.94 degreeStandard Deviation 3.04
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees60° joint position sense of more affected knee3.47 degreeStandard Deviation 3.92
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees60° joint position sense of less affected knee3.76 degreeStandard Deviation 4.73
Home Exercise After TreatmentJoint Position Sense of the More and Less Affected Knees45° joint position sense of more affected knee5.46 degreeStandard Deviation 4.62
Primary

Multiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale Score

This is a multidimensional health-related quality of life measure that combines both generic and multiple sclerosis-specific symptoms in a single instrument. The 54 items are divided into 12 multi-item and 2 single-item scales.Health distress, overall quality of life, emotional well-being, role limitations-emotional and cognitive funtion items' final scores averaged and mental composite score was calculated. Physical function, health perceptions, energy/fatigue, role limitations-physical, pain, sexual function, social function, health distress items' final scores were averaged and physical composite score was obtained.Total score was obtained by averaging the mental and physical composite scores.Final scores can be between 0-100 points for total, mental, physical and pain scores. Higher values indicate better quality of life for total, physical and mental scores and worser pain levels for pain score.

Time frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment

ArmMeasureGroupValue (MEAN)Dispersion
Isokinetic Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (total)52.20 score on a scaleStandard Deviation 17.98
Isokinetic Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (physical)50.79 score on a scaleStandard Deviation 17.02
Isokinetic Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (mental)53.59 score on a scaleStandard Deviation 20.71
Isokinetic Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (pain)54.52 score on a scaleStandard Deviation 26.9
Isokinetic Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (physical)54.69 score on a scaleStandard Deviation 18.31
Isokinetic Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (mental)59.33 score on a scaleStandard Deviation 21.81
Isokinetic Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (pain)58.57 score on a scaleStandard Deviation 30.1
Isokinetic Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (total)57.00 score on a scaleStandard Deviation 18.95
Home Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (mental)64.11 score on a scaleStandard Deviation 20.41
Home Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (physical)58.64 score on a scaleStandard Deviation 19.81
Home Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (pain)71.74 score on a scaleStandard Deviation 28.52
Home Exercise BaselineMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (total)61.38 score on a scaleStandard Deviation 18.54
Home Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (pain)67.83 score on a scaleStandard Deviation 29.94
Home Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (physical)56.69 score on a scaleStandard Deviation 22.1
Home Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (total)59.39 score on a scaleStandard Deviation 20.93
Home Exercise After TreatmentMultiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale ScoreMSQoL-54 (mental)62.07 score on a scaleStandard Deviation 22.78
Primary

Tampa Scale of Kinesiophobia

Kinesiophobia which is described as fear of movement and physical activity was evaluated using the Tampa Scale of Kinesiophobia, which is a 17-item self-report survey. The range of scores are from 17 to 68 where the higher scores indicate an increasing degree of kinesiophobia. If the total score was above 37 points, the patient was considered to have a high level of kinesiophobia.

Time frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment

ArmMeasureValue (MEAN)Dispersion
Isokinetic Exercise BaselineTampa Scale of Kinesiophobia42.42 score on a scaleStandard Deviation 5.48
Isokinetic Exercise After TreatmentTampa Scale of Kinesiophobia40.57 score on a scaleStandard Deviation 7.25
Home Exercise BaselineTampa Scale of Kinesiophobia40.33 score on a scaleStandard Deviation 6.37
Home Exercise After TreatmentTampa Scale of Kinesiophobia40.33 score on a scaleStandard Deviation 7.72
Primary

Visual Analog Scale

Pain intensity was evaluated with the Visual Analog Scale. Using a ruler, a 10 cm line was drawn which provided a range of scores from 0-100. Than the patients marked the point that showed their pain intensity on this line. A higher score in Visual Analog Scale indicates greater pain intensity.

Time frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment

ArmMeasureValue (MEAN)Dispersion
Isokinetic Exercise BaselineVisual Analog Scale40.78 score on a scaleStandard Deviation 34.16
Isokinetic Exercise After TreatmentVisual Analog Scale36.68 score on a scaleStandard Deviation 36.66
Home Exercise BaselineVisual Analog Scale41.66 score on a scaleStandard Deviation 31.11
Home Exercise After TreatmentVisual Analog Scale42.14 score on a scaleStandard Deviation 29.13

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026